PAA 2.27% 22.5¢ pharmaust limited

Certainty , What We Do Know, page-17

  1. 11,843 Posts.
    lightbulb Created with Sketch. 6001
    Look at the Company Pharmaust are now associated with ...


    In a recent S&R Research publish Global 70 kDa Ribosomal Protein S6 Kinase Market Insights, Forecast to 2025, analysts provide an in-depth analysis of the global market for 70 kDa Ribosomal Protein S6 Kinase. By analyzing its historical and forecast data, the analysis analyzes the different aspects of the market. Some are part of the coverage and are the core and emerging players being profiled ArQule, Inc., Astex Pharmaceuticals Inc, Eddingpharm, Merck KGaA, PharmAust Limited, Phoenix Biotechnology, Inc., Sentinel Oncology Limited

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.005(2.27%)
Mkt cap ! $100.1M
Open High Low Value Volume
22.0¢ 22.5¢ 21.5¢ $194.1K 889.8K

Buyers (Bids)

No. Vol. Price($)
2 4996 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 114999 4
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.